We have investigated the relaxant effects of propofol on smooth muscle tension in human omental arteries and veins to determine if endothelium-related mechanisms are involved. Isolated vessel segments were precontracted with endothelin-1 and propofol was added cumulatively (10
Propofol anaesthesia often causes undesirable hypotension. The vascular effects of propofol are poorly understood, but it seems to affect both the arterial and venous circulation, resulting in a reduction in systemic vascular resistance [1] [2] [3] [4] [5] and an increase in capacitance, 6 7 respectively. Propofol reduces vascular smooth muscle tone both directly 6 8 26 ; and indirectly, [9] [10] [11] for example via effects on sympathetic activity. Relaxation of vascular smooth muscle may be achieved by several mechanisms. Endothelium-dependent relaxation includes nitric oxide formation, 12 prostanoid synthesis, 13 and release of endothelium-derived hyperpolarizing factors activating smooth muscle potassium (K ; ) channels.
14 Endothelium-independent relaxation includes altering the availability of free cytosolic calcium, for example via effects on voltage-gated Ca 2; channel activity. 15 Several studies have attempted to explain the complex actions of propofol. Propofol has been shown to relax vascular smooth muscle in both an endothelium-dependent [16] [17] [18] [19] [20] and independent manner. [21] [22] [23] [24] Various mediators for the action of propofol have been suggested. Formation of nitric oxide or prostanoids, or both, 16 20-25 have been shown to be involved. Propofol has also been suggested to alter free cytosolic calcium concentrations in vascular smooth muscle. 19 21 22 24 26-28 It seems that propofol may interact at several cellular targets, thereby causing relaxation of vascular smooth muscle.
The aim of this study was to investigate the direct relaxant effects of propofol on human vascular smooth muscle and to determine if endotheliumrelated mechanisms are involved. Experiments were performed on intact and endothelium-denuded vessel segments and in the presence or absence of inhibitors of the synthesis or action, or both, of nitric oxide, prostanoids and endothelium-derived hyperpolarizing factors.
Materials and methods
The following compounds were used: propofol (Diprivan, Zeneca); 10% Intralipid (Pharmacia Upjohn); 9,11-dideoxy-11␣,9␣-epoxy-methanoprostaglandin F 2␣ (U46619, Sigma, thromboxane A 2 analogue); substance P acetate (SP, Sigma); endothelin-1 (ET-1, Sigma); N-nitro-L-arginine methyl ester hydrochloride (L-NAME, Sigma, inhibitor of nitric oxide synthase); sodiumindomethacin (Confortid, Dumex, inhibitor of cyclo-oxygenase); tetraethylammonium chloride (TEA, Sigma, non-selective inhibitor of K ; channels, with some preference for the high conductance Ca Vessels with an outer diameter of 0.5-1.0 mm were cut into 2-4-mm long ring segments. The segments were placed in 2-ml tissue baths on two L-shaped hooks, one of which was attached to a Grass FTO3C force-displacement transducer for isometric measurement of tension. Vessel tension was recorded on a Grass polygraph model 7b. The baths were thermostatically maintained at 37ЊC and contained lipid KRS (see composition above), which was aerated continuously with 88.5% oxygen and 11.5% carbon dioxide, to give approximate values of pH 7.4, PCO 2 5.0 kPa and PO 2 40 kPa. With the use of lipid KRS, it was possible to maintain a constant lipid concentration in the baths, even when different concentrations of propofol were added.
Vessel segments were stretched gradually to a resting tension of 6 mN during an equilibration period of 60-90 min to obtain the optimal tension level. 29 After the equilibration period, KCl 90 mmol litre 91 was added to the baths. When the resulting contraction had reached a plateau, the lipid KRS was changed three times within 10 min, during which tension returned to baseline. KCl 90 mmol litre 91 was then added 1-2 times, each time followed by wash-out until consistent contractions were elicited. With this procedure, endothelium stays functionally and anatomically intact. 30 
Experimental procedure
In the first series of experiments, we investigated the endothelium dependency of the action of propofol. The endothelium of one artery and one vein segment from six patients was removed by gentle injection of the oxygen-carbon dioxide gas mixture through the vessel lumen for 5 min. 31 To confirm that the endothelium had been removed successfully, substance P (SP), an agent which is totally dependent on a functional endothelium for its action in these preparations, 29 was added to vessel segments precontracted with the thromboxane A 2 concentration corresponds to the EC 50 value in these preparations. 32 ET-1 was first added at 1 10 99 mol litre
91
. If no contraction was elicited, the concentration was increased stepwise until the segments contracted. Within 10 min, ET-1-induced contraction reached a plateau. Pilot experiments had shown that this contraction remained constant without fade for at least 30 min. When a stable level of tension had been reached, propofol was added cumulatively in 0.5 log 10 units (10
97

-10
94 mol litre
91
) and the resulting relaxation measured. Propofol was added in a cumulative manner to assess any potential concentration dependency of the responses and to construct concentration-response curves. Each concentration of propofol was present in the bath for 2 min or until a stable tension was reached after relaxation. The cumulative concentration-response experiments with propofol took 15-20 min and were therefore performed on vessels with a stable ET-1 contraction.
In the second series of experiments, we determined by which mechanisms propofol-induced relaxation was mediated. . Control experiments were performed simultaneously on separate segments from the same patient, generating paired data with or without treatment. To exclude an effect of the solvent DMSO used in the glibenclamide and clotrimazole experiments, control experiments were also performed in the presence of DMSO at the equivalent concentration (141 mmol litre 91 ) alone. The vasoactive compounds were added to the organ baths 10 min before addition of ET-1.
STATISTICAL ANALYSIS
When similar experiments were performed on more than one segment from the same patient, the mean for each patient was calculated before presentation and statistical analysis. The number of patients is indicated by "n". Values are expressed as mean (SEM). The Wilcoxon signed rank test was used for statistical evaluation. P:0.05 was considered statistically significant and only significant differences are mentioned in the text.
Results
Propofol induced concentration-dependent relaxation in both artery and vein segments ( fig. 1A, B) .
With propofol 10
91
, relaxation was 35-70% of precontraction values; this represented betweenrather than within-patient variation. Removal of the endothelium did not affect the concentrationresponse curve of propofol ( fig. 2A, B) .
Precontraction induced by ET-1 or the response to propofol was not affected by indomethacin (artery n:6, vein n:5), L-NAME (artery n:7, vein n:8), glibenclamide (artery n:5, vein n:5), 4-AP (artery n:7, vein n:7), clotrimazole (artery n:6, vein n:5), atropine (artery n:5, vein n:5) or the solvent DMSO (artery n:4, vein n:4) (data not shown).
An increase in extracellular KCl concentration did not affect precontraction induced by ET-1, but reduced the relaxation induced by propofol in both artery and vein segments ( fig. 3A, B , propofol-induced relaxation was inhibited only at the highest concentration of propofol and only in veins ( fig. 4A, B) .
Discussion
We have shown that propofol produced concentration-dependent relaxant effects on human omental arteries and veins. The propofol concentrations needed were high and exceeded those seen clinically. Clinically relevant plasma concentrations of propofol have been estimated to be 1-5 10 95 mol litre
91
. 33 34 However, in vitro and in vivo concentrations are not easy to compare, as the in vivo situation cannot be mimicked completely. Several factors may interfere, such as plasma protein binding and lipid solubility, two factors which are both reported to be important for propofol. 25 35 Hence the clinical relevance of our findings remains to be determined. The poor water solubility of propofol requires the use of a lipid solvent for its administration. In this study, we chose 10% Intralipid as it is the vehicle used clinically. The observed effects of propofol cannot be a result of 10% Intralipid as the equivalent concentration of Intralipid was always present in the control organ baths. The dependency of a functional endothelium for the action of propofol has been investigated in several species and vascular beds. Our results indicate that propofol relaxes human omental arteries and veins in an endothelium-independent manner. This also occurs in the rat aorta, 21 23 25 canine coronary artery, 22 pig coronary artery 24 and rat pulmonary artery. 25 Propofol has also been found to have endotheliumdependent effects. In the bovine coronary artery, propofol is more potent in endothelium-intact vessel segments than in endothelium-denuded vessel segments. 18 In rat coronary artery, the relaxant effect of propofol is endothelium-dependent. 20 The view that propofol acts differently depending on the species or vascular region is supported by other workers.
L-NAME and indomethacin did not affect the responses to propofol. This indicates that neither nitric oxide formation nor prostanoid synthesis is involved in propofol-induced relaxation in human omental arteries and veins. In contrast, in the rat coronary artery, nitric oxide and prostanoids are important for propofol-induced relaxation, 20 and in rat aorta and pulmonary artery, prostanoid synthesis is reported to be involved in propofol-induced relaxation. 25 Our results indicate that propofol may not interact with endothelial mechanisms at basal conditions in vitro. However, in the in vivo situation, there could be a varying degree of stimulation of the endothelium, for example by substance P and bradykinin, to produce nitric oxide, prostanoids or endothelium-derived hyperpolarizing factor (EDHF) that could affect smooth muscle cells. Any potential effect of propofol on these mechanisms remains to be elucidated.
The relaxant effect of propofol in human omental arteries and veins was reduced by increased extracellular K ; concentration. Membrane hyperpolarization results from changes in ion conductance. By increasing the extracellular K ; concentration, the K ; gradient over the smooth muscle cell membrane becomes smaller, and thus hyperpolarization is inhibited. 14 The effect of KCl implies that hyperpolarization may be involved in propofol induced relaxation of human omental arteries and veins. Indeed, a similar reduction in the responses to propofol when extracellular K ; was increased have also been found in the pig coronary artery, where propofol caused less relaxation in vessel segments precontracted with KCl than with norepinephrine, 5-hydroxytryptamine or carbachol. 24 Moreover, in human omental arteries and veins, propofol is less potent in inhibiting KCl-induced contractions than contractions induced by U46619. 28 The reverse of these findings seems to be true for the rat thoracic aorta, where propofol produced greater relaxation in vessel segments precontracted with KCl than with phenylephrine. 21 The evidence for propofol-induced hyperpolarization in our study is indirect. Electrophysiological measurements of actual membrane potential are needed to verify the findings.
Hyperpolarization can be achieved by activating K ; channels, resulting in K ; efflux and reduction of smooth muscle tone. 36 To investigate if K ; channels are involved in propofol-induced relaxation, the effect of three inhibitors of K ; channels (TEA, glibenclamide and 4-AP) was investigated. Glibenclamide and 4-AP did not affect the responses to propofol, indicating that neither K ATP nor K V is activated by propofol. In contrast, TEA inhibited propofol-induced relaxation. The effect of TEA indicates that propofol in human omental arteries and veins may activate BK Ca , which results in hyperpolarization and relaxation. In canine coronary arteries, TEA at these concentrations did not affect the response to propofol, 22 again confirming the complex and variable actions of propofol.
The TEA concentration required for inhibition of propofol-induced relaxation was high and selectivity for BK Ca might be questioned. In addition, TEA has been proposed to have muscarinic antagonist properties. 37 In our study, the muscarinic antagonist atropine had no effect on propofol-induced relaxation, indicating that relaxation was not mediated via muscarinic receptors. This also implies that the effect of TEA on propofol-induced relaxation is unlikely to be non-specific inhibition of muscarinic receptors.
Clotrimazole, an inhibitor of the cytochrome P450 system, has been shown previously to inhibit nitric oxide-prostanoid-independent relaxation. -activated K ; channel (I KCa ). 39 In our study, clotrimazole had no effect on propofolinduced relaxation, indicating that propofol may not relax human omental arteries and veins via a cytochrome P450-derived product, and it does not activate I KCa . In summary, the relaxant effect of propofol on human omental arteries and veins was endotheliumindependent and probably involved hyperpolarization, possibly resulting from activation of BK Ca .
